---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-080268"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2024-09-19T23:59:59+00:00"
generated_at: "2026-05-31T03:46:22.607358+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Ilan Shiloah resigns from Silexion Therapeutics board effective Sept 16, 2024

## Summary
- Ilan Shiloah resigned as independent director and from audit, compensation, and governance committees.
- Resignation effective September 16, 2024; cited competing time demands.
- No disagreement with company operations, policies, or practices stated.
- Shiloah served since business combination closing on August 15, 2024.
- No replacement named at this time.

## SEC filing metadata
- accession: 0001213900-24-080268
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2024-09-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000121390024080268/0001213900-24-080268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000121390024080268/ea0215110-8k_silexion.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-080268
- JSON: https://secwatch.observer/filing/0001213900-24-080268.json
- Plain text: https://secwatch.observer/filing/0001213900-24-080268.txt

## Key facts
- Executive change
  Ilan Shiloah resigned as independent director at Silexion Therapeutics Corp.
  - Action: resigned
  - Role: independent director
  source text: On September 16, 2024, Ilan Shiloah, an independent director serving on the board of directors (the “Board”) of Silexion Therapeutics Corp, a Cayman Islands exempted company (the “Company”), informed the Company that he has resigned from the Board, including from his membership on each of the committees of the Board— the audit committee, the compensation committee, and the corporate governance and nominating committee— effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2022416/000121390024080268/0001213900-24-080268-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.